SECTOR : Biotech
ENTRY DATE : 2019
BUSINESS : Venture Capital
WEB : nhtheraguix.com
First nanomedicine for cancer combining imaging and radiotherapy
NH TherAguix is a French biotech company developing an innovative nanomedicine that improve radiation therapy benefits without modifying current clinical workflows.
PRESS RELEASE :
11/04/2019 • NH TherAguix, a start-up specializing in nanomedicine for cancer radiotherapy, announces a €13 million round of fundraising, led by Bpifrance